Synexo Group (SYNEXO) Investor Presentation summary
Event summary combining transcript, slides, and related documents.
Investor Presentation summary
2 Jan, 2026Business overview and growth strategy
Focuses on niche B2B software with high recurring revenue and low churn, targeting profitable organic growth and accretive M&A.
Operates with a diversified customer base of over 1,000 clients and 45 resellers, emphasizing data security and low customer churn.
Management and board have significant industry experience and own 48.5% of shares, aligning interests with shareholders.
M&A strategy targets non-cyclical, mission-critical software companies, with 16 targets in the pipeline and 4 in active discussions.
Inspired by Constellation Software's long-term value creation model, focusing on quality acquisitions and reinvestment.
Financial performance and key metrics
Achieved SEK 4.7m ARR as of November 2025, up 46% year-over-year pro forma, with signed ARR at SEK 9.0m.
Net retention rate at 116% and customer churn at 3.1% LTM, reflecting strong customer loyalty and upsell.
Gross margin at 62% LTM, with Cash-EBITDA at SEK -0.9m LTM; both subsidiaries are cash-flow positive.
Lean organization with 3.5 FTEs, supporting scalable growth and significant operating leverage.
No interest-bearing debt, SEK 3.2m cash, and no potential earn-outs; self-funded with positive operating working capital.
Market opportunity and outlook
Operates in the global Backup-as-a-Service market, projected to grow at 31.8% CAGR to USD 33.18bn by 2030.
Internal market includes resellers seeking to switch suppliers, representing additional ARR potential.
Targets >20% average organic annual growth and >70% gross margin in the medium term.
2026 goals: live ARR of SEK 12m (100% organic growth), total signed ARR >SEK 18m, and continued cost discipline.
Profits to be reinvested in acquisitions or distributed to shareholders, maintaining a solid balance sheet.
Latest events from Synexo Group
- ARR up 61% y/y, strong upsell, low churn, and M&A activity drive growth and margin targets.SYNEXO
Q4 202526 Feb 2026 - Q3 2025 delivered 56% pro forma revenue growth, 63% gross margin, and strong ARR expansion.SYNEXO
Q3 202528 Nov 2025 - No operations remain after subsidiary sale; future depends on a pending data storage acquisition.SYNEXO
Q2 202521 Aug 2025 - Sales dropped sharply and losses deepened, with recovery delayed to 2025/2026.SYNEXO
Q3 202413 Jun 2025 - Net sales dropped 43.6% and a SEK 2.6 million order was secured from Pathogen Systems Inc.SYNEXO
Q2 202413 Jun 2025 - Sales up, losses persist; MedTech order and new partnerships drive future focus.SYNEXO
Q1 20256 Jun 2025 - Omsättning föll 39% och fortsatt förlust kräver ny finansiering och omstrukturering.SYNEXO
Q4 20245 Jun 2025